Embedded Files
PharmedOut's Letter to the FDA on label changes and advisory committee meetings
PharmedOut is a project at Georgetown University Medical Center that advances evidence-based prescribing and educates health care professionals and students about pharmaceutical and medical device marketing practices. PharmedOut provides educational slideshows, videos, events, and information about CME courses free of industry sponsorship.
No Labeling Changes without an Advisory Committee Meeting
No Labeling Changes without an Advisory Committee Meeting
Removing labeling warnings from drugs without robust scientific assessment and evidence puts patients at risk of harm. Over 75 clinicians and researchers signed on to a letter urging the FDA to convene an Advisory Committee meeting to assess potential long-term benefits and harms before making any labeling changes to hormone products.
PharmedOut opposes label change on vaginal estrogens
PharmedOut opposes label change on vaginal estrogens
On Thursday, July 17th, the Food and Drug Administration will host a panel on menopausal hormone therapy that is expected to minimize harms of hormones. PharmedOut sent a letter to the FDA to support maintaining current warnings on hormone products, including vaginal estrogens, until adequate studies support a change.
Editorial published in American Family Physician, "Menopausal Hormone Therapy: Limited Benefits, Significant Harms"
Editorial published in American Family Physician, "Menopausal Hormone Therapy: Limited Benefits, Significant Harms"
Dr. Fugh-Berman and Dr. Barbara Mintzes summarize the evidence on menopausal hormone therapy (7/15/2025).
Women's Health Initiative
Women's Health Initiative
Show some love for women's health research! After the Women's Health Initiative funding was threatened in April 2025, we want to show our appreciation for this incredible, historic study.
Join us by sporting an "I ❤️ WHI" button.
Write us at pharmedout@gmail.com with your mailing address and we'll happily make and send you one!
PharmedOut's latest project, the Pharmanipulation Podcast, is a new show dedicated to the topics of evidence-based medicine and industry influence on medical information and public health.
PharmedOut letter demands that the Federation of State Medical Boards remove CME credits from a menopause documentary rife with misinformation
PharmedOut letter demands that the Federation of State Medical Boards remove CME credits from a menopause documentary rife with misinformation
Signed by 16 researchers, clinicians and women's health experts, the letter counters false and dangerous statements made in a documentary on menopause and hormone therapy that was accredited by the FSMB.
Read coverage by STAT News here.
What Needs to Change at the FDA? Protecting and Advancing Public Health
What Needs to Change at the FDA? Protecting and Advancing Public Health
Free CME Activity
Free CME Activity
"Mild Cognitive Impairment and Alzheimer's: First, do no harm" is an online continuing education activity that covers new Alzheimer's treatments and how to best care for dementia patients.
How Pharma Grooms Patients and Advocacy Groups to Sell Drugs
How Pharma Grooms Patients and Advocacy Groups to Sell Drugs
Learn from advocates from the US and Canada about how industry uses individual patients and patient advocacy organizations to affect perceptions about drug efficacy and harms.
Pharma Marketing Resources
Pharma Marketing Resources
PharmedOut, with support from Kaiser Permanente, is pleased to announce our Pharma Marketing Hub, which contains factsheets and literature summaries on 15 pharmaceutical marketing topics.
Click here for more information and to download helpful resources.
Pharma-free CME
Pharma-free CME
We provide access to free online CME from the CDC, TCEO, NIH, AHRQ, and more.
Dr. Fugh-Berman and the Opioid Epidemic
Dr. Fugh-Berman and the Opioid Epidemic
The Washington Post released a documentary and companion article on the opioid epidemic and the immense corporate marketing push behind it. Dr. Fugh-Berman appears at the 2:33 minute mark commenting on how industry persuaded physicians to prescribe opioids.
Follow PharmedOut on X
Follow PharmedOut on X
Report abuse